CLAIM #27424 · GILD (GILD) · 2026Q1 earnings call · May 7, 2026 · due Aug 31, 2026
“We expect a regulatory decision based on priority review in August.”
Dietmar Berger · Chief Medical Officer
PENDING
graded after results covering Aug 31, 2026 are reported
How to check this claim
Look at: FDA regulatory decision (approval action) on the product under priority review
It came true if: FDA issues a decision (approval, complete response letter, or other action) by August 31, 2026
Where: Company press release / FDA action announcement (company-disclosed regulatory update, 8-K or press release)
Verify independently
SEC filings for GILD ↗ · Claim quote is verbatim from the 2026Q1 earnings call.